scispace - formally typeset
F

Françoise Bonichon

Researcher at Argonne National Laboratory

Publications -  52
Citations -  2611

Françoise Bonichon is an academic researcher from Argonne National Laboratory. The author has contributed to research in topics: Breast cancer & Soft tissue sarcoma. The author has an hindex of 22, co-authored 52 publications receiving 2438 citations.

Papers
More filters
Journal ArticleDOI

Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma

TL;DR: The FNCLCC system showed slightly increased ability to predict distant metastasis development and tumor mortality, and the use of this system to evaluate STS aggressiveness might be favored.
Journal ArticleDOI

Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group.

TL;DR: In this article, the authors performed univariate and multivariate analyses for metastasis-free survival for the overall soft tissue sarcoma group and for every main histologic type, with the exception of malignant schwannomas and rhabdomyosarcomas.
Journal ArticleDOI

A Critical Analysis of Treatment Strategies in Desmoid Tumours: A Review of a Series of 106 Cases

TL;DR: Desmoids are relatively indolent tumours needing different approaches than sarcomas, and direct surgery is advisable only in primary lower trunk wall/girdle locations, and wait-and-see and medical treatment is preferable in other types of presentations.
Journal ArticleDOI

Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma

TL;DR: This study confirms the feasibility of external postoperative radiotherapy with an acceptable level of toxicity, however, the high rate of local relapses does not demonstrate the usefulness of radiotherapy at the level of dose used and further preferably randomized studies should be planned.
Journal ArticleDOI

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers

TL;DR: This study on a large unicentric series and with a long follow-up confirms the prognostic significance of vascular emboli in patients with operable node-negative breast carcinoma and finds them to be accurately detectable by a simple routine and non-time-consuming method.